The Limited Times

Now you can see non-English news...

New drug for corona: FDA experts recommend approving the pill from the soup company | Israel today

2021-11-30T22:47:54.300Z


The hope: Mark's pill approval, and the expected approval of Pfizer's pill that shows even better results - will change the course of the epidemic


The FDA's panel of experts last night (Tuesday) recommended the soup from the soup company to treat severe symptoms of the corona virus. 

Experts voted by a majority of 13 to 10 against the treatment of the pill, which is designed to help adults who are at risk of developing severe coronary heart disease.

The hope is that Merck's pill approval, and the expected approval of Pfizer's pill that shows even better results (reduces mortality, hospitalizations and serious illness by 89%) will change the course of the epidemic.

The two drugs, which are relatively cheap, can also be distributed quickly to third world countries where only a small percentage of the population is vaccinated, and of course they will help reduce mortality and the burden on hospitals in Western countries as well.

The fact that billions in underdeveloped countries have not yet been vaccinated against corona prevents the world from emerging from the epidemic, and enables the development of new variants such as the omicron, which could break the vaccine defense and trickle down to developed countries.

The consensus among doctors and scientists is that in order to leave the corona behind, the virus must also be overcome in the Third World, and the hope is that the new drugs will make this goal much closer to achievement.

Were we wrong?

Fixed!

If you found an error in the article, we'll be happy for you to share it with us

Source: israelhayom

All news articles on 2021-11-30

You may like

News/Politics 2024-03-26T17:54:22.279Z

Trends 24h

News/Politics 2024-03-28T06:04:53.137Z

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.